Advertisement
Screener

NewcelX Ltd. (NCEL) Form 6-K: Report of foreign private issuer, 2025

1.9 / 5 stars · 8/21 Roast Me

Add as a preferred source on Google

NewcelX Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-12-11: Form 6-K; Period of report 2025-12-11; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0269296-6k_newcelx.htm.
  • 2025-11-20: Form 6-K; Period of report 2025-11-20; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0266432-6k_newcelx.htm.
  • 2025-11-17: Form 6-K; Period of report 2025-11-17; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0265974-6k_newcelx.htm.
  • 2025-11-07: Form 6-K; Period of report 2025-11-07; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea0264479-6k_newcelx.htm.
FiledFormPeriod of reportDescriptionDocument
2025-12-116-K2025-12-11REPORT OF FOREIGN PRIVATE ISSUERea0269296-6k_newcelx.htm
2025-11-206-K2025-11-20REPORT OF FOREIGN PRIVATE ISSUERea0266432-6k_newcelx.htm
2025-11-176-K2025-11-17REPORT OF FOREIGN PRIVATE ISSUERea0265974-6k_newcelx.htm
2025-11-076-K2025-11-07REPORT OF FOREIGN PRIVATE ISSUERea0264479-6k_newcelx.htm
2025-11-046-K2025-11-04REPORT OF FOREIGN PRIVATE ISSUERea0263614-6k_newcelx.htm
2025-11-036-K2025-11-03REPORT OF FOREIGN PRIVATE ISSUERea0263562-6k_newcel.htm
2025-10-306-K2025-10-30REPORT OF FOREIGN PRIVATE ISSUERea0263121-6k_nlspharma.htm
2025-10-306-K2025-10-30REPORT OF FOREIGN PRIVATE ISSUERea0263090-6k_nlspharma.htm
2025-10-296-K2025-10-29REPORT OF FOREIGN PRIVATE ISSUERea0262679-6k_nlspharma.htm
2025-10-296-K2025-10-29REPORT OF FOREIGN PRIVATE ISSUERea0262882-6k_nlspharma.htm
2025-10-286-K2025-10-28REPORT OF FOREIGN PRIVATE ISSUERea0262869-6k_nlspharma.htm
2025-10-276-K2025-10-27REPORT OF FOREIGN PRIVATE ISSUERea0262581-6k_nlspharma.htm
2025-10-236-K2025-10-23REPORT OF FOREIGN PRIVATE ISSUERea0262070-6k_nlspharma.htm
2025-10-106-K2025-10-09REPORT OF FOREIGN PRIVATE ISSUERea0260720-6k_nlspharma.htm
2025-10-066-K2025-06-30REPORT OF FOREIGN PRIVATE ISSUERea0259852-6k_nlspharm.htm
2025-09-306-K2025-09-30REPORT OF FOREIGN PRIVATE ISSUERea0259375-6k_nlspharma.htm
2025-09-196-K2025-09-19REPORT OF FOREIGN PRIVATE ISSUERea0258051-6k_nlspharma.htm
2025-09-106-K2025-09-10REPORT OF FOREIGN PRIVATE ISSUERea0256720-6k_nlspharma.htm
2025-09-046-K2025-09-04REPORT OF FOREIGN PRIVATE ISSUERea0255971-6k_nlspharma.htm
2025-08-296-K2025-08-29REPORT OF FOREIGN PRIVATE ISSUERea0254962-6k_nlspharma.htm
2025-08-256-K2025-08-25REPORT OF FOREIGN PRIVATE ISSUERea0254540-6k_nlspharma.htm
2025-08-066-K2025-08-06REPORT OF FOREIGN PRIVATE ISSUERea0251991-6k_nlspharma.htm
2025-07-186-K2025-07-18REPORT OF FOREIGN PRIVATE ISSUERea0249553-6k_nlspharma.htm
2025-07-176-K2025-07-17REPORT OF FOREIGN PRIVATE ISSUERea0249275-6k_nlspharma.htm
2025-07-016-K2025-07-01REPORT OF FOREIGN PRIVATE ISSUERea0247800-6k_nlspharma.htm
2025-07-016-K2025-07-01REPORT OF FOREIGN PRIVATE ISSUERea0247659-6k_nlspharm.htm
2025-06-306-K2025-06-30REPORT OF FOREIGN PRIVATE ISSUERea0247391-6k_nlspharm.htm
2025-06-166-K2025-06-16REPORT OF FOREIGN PRIVATE ISSUERea0245735-6k_nlspharm.htm
2025-06-106-K2025-06-10REPORT OF FOREIGN PRIVATE ISSUERea0245208-6k_nlspharm.htm
2025-06-066-K2025-06-06REPORT OF FOREIGN PRIVATE ISSUERea024489001-6k_nlspharm.htm
2025-05-056-K2025-05-05REPORT OF FOREIGN PRIVATE ISSUERea0240935-6k_nlspharma.htm
2025-04-246-K2025-04-24REPORT OF FOREIGN PRIVATE ISSUERea0239447-6k_nlspharm.htm
2025-04-156-K2025-04-15REPORT OF FOREIGN PRIVATE ISSUERea0237490-6k_nlspharma.htm
2025-04-046-K/A2025-04-04AMENDMENT NO. 1 TO FORM 6-Kea0237180-6ka1_nlspharma.htm
2025-03-316-K2025-03-31REPORT OF FOREIGN PRIVATE ISSUERea0236265-6k_nlspharma.htm
2025-03-106-K2025-03-10REPORT OF FOREIGN PRIVATE ISSUERea0233622-6k_nlspharma.htm
2025-02-276-K2025-02-27REPORT OF FOREIGN PRIVATE ISSUERea0232254-6k_nlspharma.htm
2025-02-256-K2025-02-25REPORT OF FOREIGN PRIVATE ISSUERea0231992-6k_nlspharma.htm
2025-02-106-K2025-02-10REPORT OF FOREIGN PRIVATE ISSUERea0230492-6k_nlspharma.htm
2025-01-316-K2025-01-31REPORT OF FOREIGN PRIVATE ISSUERea0229351-6k_nlspharma.htm
2025-01-316-K2025-01-31REPORT OF FOREIGN PRIVATE ISSUERea0229241-6k_nlsphar.htm
2025-01-306-K2025-01-30REPORT OF FOREIGN PRIVATE ISSUERea0229151-6k_nlsphar.htm
2025-01-286-K2025-01-28REPORT OF FOREIGN PRIVATE ISSUERea0228867-6k_nlsphar.htm
2025-01-166-K2025-01-16REPORT OF FOREIGN PRIVATE ISSUERea0227886-6k_nlsphar.htm
2025-01-146-K2025-01-14CURRENT REPORTea0227681-6k_nlspharma.htm
2025-01-086-K2025-01-08REPORT OF FOREIGN PRIVATE ISSUERea0227105-6k_nlspharma.htm
2025-01-076-K2025-01-07REPORT OF FOREIGN PRIVATE ISSUERea0227024-6k_nlspharma.htm
Advertisement